Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes
- PMID: 7532283
- PMCID: PMC230399
- DOI: 10.1128/MCB.15.3.1747
Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes
Abstract
The rate of transcription of the hepatic phosphoenolpyruvate carboxykinase (PEPCK) and insulin-like growth factor-binding protein 1 (IGFBP-1) genes is stimulated by glucocorticoids and inhibited by insulin. In both cases, the effect of insulin is dominant, since it suppresses both basal and glucocorticoid-stimulated PEPCK or IGFBP-1 gene transcription. Analyses of both promoters by transfection of PEPCK or IGFBP-1-chloramphenicol acetyltransferase fusion genes into rat hepatoma cells has led to the identification of insulin response sequences (IRSs) in both genes. The core IRS, T(G/A)TTTTG, is the same in both genes, but the PEPCK promoter has a single copy of this element whereas the IGFBP-1 promoter has two copies arranged as an inverted palindrome. The IGFBP-1 IRS and PEPCK IRS both bind the alpha and beta forms of hepatic nuclear factor 3 (HNF-3), although the latter does so with a sixfold-lower relative affinity. Both the PEPCK and the IGFBP-1 IRSs also function as accessory factor binding sites required for the full induction of gene transcription by glucocorticoids. A combination of transient transfection and DNA binding studies suggests that HNF-3 is the accessory factor that supports glucocorticoid-induced gene transcription. In both genes, the HNF-3 binding site overlaps the IRS core motif(s). A model in which insulin is postulated to mediate its negative effect on glucocorticoid-induced PEPCK and IGFBP-1 gene transcription indirectly by inhibiting HNF-3 action is proposed.
Similar articles
-
A novel DNA/protein complex interacts with the insulin-like growth factor binding protein-1 (IGFBP-1) insulin response sequence and is required for maximal effects of insulin and glucocorticoids on promoter function.Prog Growth Factor Res. 1995;6(2-4):119-29. doi: 10.1016/0955-2235(95)00020-8. Prog Growth Factor Res. 1995. PMID: 8817653 Review.
-
Potential convergence of insulin and cAMP signal transduction systems at the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter through CCAAT/enhancer binding protein (C/EBP).J Biol Chem. 1994 Dec 2;269(48):30419-28. J Biol Chem. 1994. PMID: 7982956
-
Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter.Endocrinology. 1994 Feb;134(2):736-43. doi: 10.1210/endo.134.2.7507835. Endocrinology. 1994. PMID: 7507835
-
Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences.J Biol Chem. 2001 Sep 7;276(36):33705-10. doi: 10.1074/jbc.M101215200. Epub 2001 Jul 9. J Biol Chem. 2001. PMID: 11445561
-
Dexamethasone stimulation of rat insulin-like growth factor binding protein-1 (IGFBP-1) promoter activity involves the interaction of multiple transcription factors.Prog Growth Factor Res. 1995;6(2-4):131-40. doi: 10.1016/0955-2235(95)00021-6. Prog Growth Factor Res. 1995. PMID: 8817654 Review.
Cited by
-
Surgical removal of visceral adipose tissue: effects on insulin action.Curr Diab Rep. 2003 Jun;3(3):201-6. doi: 10.1007/s11892-003-0064-3. Curr Diab Rep. 2003. PMID: 12762966 Review.
-
Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):227-32. doi: 10.1073/pnas.0300372101. Epub 2003 Dec 23. Proc Natl Acad Sci U S A. 2004. PMID: 14694204 Free PMC article.
-
Cloning and characterization of the promoter for the liver isoform of the rat carnitine palmitoyltransferase I (L-CPT I) gene.Biochem J. 1998 Feb 15;330 ( Pt 1)(Pt 1):217-24. doi: 10.1042/bj3300217. Biochem J. 1998. PMID: 9461513 Free PMC article.
-
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12121-6. doi: 10.1073/pnas.0812547106. Epub 2009 Jul 8. Proc Natl Acad Sci U S A. 2009. PMID: 19587243 Free PMC article.
-
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?Front Endocrinol (Lausanne). 2018 Apr 9;9:117. doi: 10.3389/fendo.2018.00117. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29686648 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials